CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus infectionsCompany to present Phase 1 data and updates from ongoing Phase 1b study conducted ...

To date, there are no approved vaccines or antiviral treatments for human norovirus, the leading cause of acute gastroenteritis outbreaks worldwide with more than 685 million infections each year.

CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory ...

Cocrystal Pharma, Inc. announced that its investigational antiviral drug CDI-988 has shown strong efficacy against the newly dominant norovirus variants GII.17 and previously prevalent GII.4, amid a ...

The highly contagious norovirus – popularly known as "stomach flu" or the "winter vomiting bug" – is now surging through the U.S. The number of outbreaks is up significantly over previous years, ...

Add Yahoo as a preferred source to see more of our stories on Google. Kinga Krzeminska/Getty Images Norovirus outbreaks are popping up around the United States, causing concern during a winter when ...

Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...

Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...

Once norovirus is circulating, it can quickly become an outbreak.

We might be near the end of winter, but the spread of norovirus shows little sign of slowing down. The number of people in hospital with the winter vomiting bug has hit a record h ...

Seaweed may be a popular food item, but it has certain properties that mean it could act as a shield within the human body, effectively blocking norovirus infection. To date, there are no approved ...